Traders should monitor for potential downward pressure on TDOC shares, especially given the concentration of selling among top executives. Absence of offsetting buy signals or positive news increases concern. Watch for commentary around liquidity needs or pre-arranged 10b5-1 plans, which could mitigate negative interpretation.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $5.16entry
- T+1 · 9mo ago −1.16%α −0.25% · $5.10
- T+5 · 8mo ago +2.71%α +3.92% · $5.30
- T+20 · 8mo ago −0.39%α +7.55% · $5.14
- T+60 · 6mo ago +27.71%α +18.39% · $6.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple high-level executives at Teladoc Health, including CEO Charles Divita and other C-suite leaders, conducted open-market share sales totaling approximately $644K over a two-day window. These sales coincided with derivative exercises, but the open-market dispositions represent material insider selling by top leadership.
Key Financial Metrics
Key Facts
- CEO Charles Divita sold $256.6K worth of shares in open-market transactions.
- Four C-suite executives and one president sold shares openly for a total of $644K across two days.
- Total open-market sale value represents ~0.07% of Teladoc's $921M market cap, modest but concentrated among top executives.
- All sales occurred at $5.117 per share, indicating coordinated timing near a consistent price point.
- Concurrent with non-cash derivative exercises (M-coded transactions), which are routine and do not reflect economic value transfer.
Financial Impact
$644,533 in open-market share sales by insiders over 7 days
Risk Factors
- Perception of insider pessimism regarding near-term stock performance or business fundamentals.
- Potential for follow-on selling or lack of confidence in current valuation levels.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (10 trades, 7d window) | cluster-TDOC-1772574377769 |
Track record
24 reports on TDOC
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers